newsfilter
← Latest News
GlobeNewswire·

REMINDER TO VOTE: 20/20 BioLabs Special Meeting of Stockholders to Be Held December 9, 2026

AIDX
  • 20/20 BioLabs, Inc. (NASDAQ: AIDX) board of directors recommends a vote FOR all proposals at its Special Meeting on December 9, 2026.
  • The meeting will occur at 10:00 a.m. Eastern Time via a virtual live webcast only.
  • Stockholders of record as of October 20, 2026, are eligible to vote.
  • Proposal 1 seeks authorization for the board to implement a reverse stock split at a ratio between 1-for-2 and 1-for-250 before December 31, 2028.
  • Proposal 2 seeks approval to adjourn the Special Meeting if necessary to solicit additional proxies.
  • The reverse stock split authorization aims to provide flexibility to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
  • Voting options include online submission at www.iproxydirect.com/AIDX, by phone at 1-866-752-VOTE, or by fax.
  • Shares held in street name require voting instructions from the broker, bank, or nominee.
  • Stockholders must use a control number from their notice card to attend the webcast at https://edge.media-server.com/mmc/go/AIDX2026SGM.
  • 20/20 BioLabs develops AI-powered, laboratory-based blood tests under the OneTest brand for cancer detection and longevity.